The Dow Jones Industrial Average dipped below 48,000 on Monday, affected by rising 10-year Treasury yields. The S&P 500 declined by 0.5%, the Nasdaq by 0.4%, and the Dow by 0.6%. This drop follows expectations for an interest rate cut during the Federal Reserve’s meeting on December 10. Markets currently price in a 90% chance of a 25-basis-point rate cut.
Focus on Fed Strategy
Attention shifts to Fed Chair Jerome Powell and his strategy beyond 2025, with analysts suggesting a cautious approach. A steady rate decision could lead to a sharp drop in stock prices. Despite an overall muted session, tech stocks shone, with Broadcom reaching new highs. Confluent and companies like Wave Life Sciences surged following promising announcements.
The focus on AI technology remains intense, with strong revenue growth projections for Nvidia and Palantir Technologies. However, there are concerns about whether enthusiasm for AI could lead to a tech bubble.
In other global updates, the Reserve Bank of Australia is likely to keep the Official Cash Rate at 3.6%. Meanwhile, markets also await decisions from Canada, Australia, and Switzerland, expecting them to hold their rates.
Market Sentiment and Strategies
With the Federal Reserve’s rate decision expected tomorrow, the focus is not on the cut itself but on the guidance for 2026. Since a 25-basis-point cut is over 90% priced in, we should consider buying volatility through options on the VIX. Any deviation from the script by Chair Powell could cause a sharp market move, and elevated volatility would be profitable regardless of the direction.
The market’s recent run-up to the Dow 48,000 level feels fragile, especially with the 10-year Treasury yield climbing again. This suggests we should look at purchasing protective puts on major indices like the S&P 500. This strategy acts as insurance against a “sell the news” reaction or a surprisingly hawkish tone from the Fed about future inflation.
We must remain cautious about the excitement surrounding AI stocks, which reminds us of the lead-up to the DotCom bubble in the late 1990s. After seeing stocks like Nvidia surge over 230% in 2023 alone, it is wise to hedge these positions. Selling covered calls on high-flying tech names can generate income while providing a small buffer against a potential pullback.
There is clear momentum in the biotechnology sector, especially with ongoing breakthroughs in obesity drugs. The market for these treatments is projected to exceed $100 billion by the end of the decade, making call options on biotech ETFs a compelling trade. The significant stock jumps in companies with positive trial data show how sensitive this sector is to good news.
The divergence in central bank policy, with the Fed expected to cut while the Reserve Bank of Australia and others hold steady, points toward a stronger U.S. dollar. This is a classic setup for currency traders. We could use options on currency ETFs to bet on the dollar rising against a basket of other currencies in the coming weeks.
